Guerbet Partners with Imalogix on Dose Optimization with AI

Guerbet offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. Imalogix’s AI and workflow solutions support healthcare providers in better understanding and managing process, quality and safety relation to diagnostic imaging services, interventional procedures, and comply with evolving regulatory standards.

The Imalogix self-learning neural network enables organizations to understand and benchmark in real-time best practices from the mass learnings across a network of providers to drive continuous improvement. Deep learning recommendations highlight where and how changes can be made to enable organizations to proactively change behavior down to the scanner, protocol and operator level. Insights into procedure length, utilization, and workflow help organizations understand how to become more efficient and optimize patient flow.

The commercial partnership combines Guerbet's leadership in diagnostic and interventional imaging with the cloud-based human and machine-intelligence capabilities of Imalogix to proactively identify areas that impact care delivery to reduce variability and improve the quality, safety and efficiency of care around radiation dose management.

"Guerbet is thrilled to deliver an AI-powered solution that brings together data in a meaningful way to evolve the standard of care to patients for managing radiation dose," said Massimo Carrara, Guerbet Vice President for North America. "By partnering with such a recognized expert in the field, Guerbet remains focused on offering the best in diagnostic imaging in a rapidly evolving industry."

"We are excited to partner with Guerbet who has an extensive track record of innovation. This partnership further demonstrates their commitment to grow and expand their digital offerings to bring best-in-class solutions to their customers," said John Heil, CEO of Imalogix.